RO 3280
CAS No. 1062243-51-9
RO 3280( RO3280 | RO-3280 | RO 3280 | Ro5203280 )
Catalog No. M10275 CAS No. 1062243-51-9
RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | In Stock |
|
| 5MG | 131 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 388 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRO 3280
-
NoteResearch use only, not for human use.
-
Brief DescriptionRO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1)
-
DescriptionRO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3nM.
-
In Vitro——
-
In Vivo——
-
SynonymsRO3280 | RO-3280 | RO 3280 | Ro5203280
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorPLK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1062243-51-9
-
Formula Weight543.61
-
Molecular FormulaC27H35F2N7O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 100 mg/mL (183.95 mM); DMSO: 100 mg/mL (183.95 mM)
-
SMILESO=C(NC1CCN(C)CC1)C2=CC=C(NC3=NC=C(N4C)C(N(C5CCCC5)CC(F)(F)C4=O)=N3)C(OC)=C2
-
Chemical Name4-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen S, et al. Bioorg Med Chem Lett, 2012, 22(2), 1247-1250.
molnova catalog
related products
-
CFI-400945
CFI-400945 is an potent, selective and orally active inhibitor of?polo-like kinase 4(PLK4; Ki value of 0.26 nM).
-
TAK-960
TAK-960 is an orally bioavailable selective inhibitor of Plks with IC50 values of 0.8 16.9 and 50.2 nM for Plk1 Plk2 and Plk3 respectively.
-
T521
T521 is a selective inhibitor of the PBD of Plk1 and shows no inhibitory effect on Plk2 and Plk3.
Cart
sales@molnova.com